Biosimilar Safety Surveillance: A Guide to Adverse Event Monitoring
Explore how biosimilar safety surveillance works, from FDA/EMA frameworks to the challenges of immunogenicity and the critical need for accurate product attribution.
Read MoreTag: biosimilar safety surveillance